Experimental KRAS Vaccine Generates Immune Response Against Pancreatic Cancer in People at High Risk

Could A Vaccine Prevent Pancreatic Cancer In Those At High Risk?

Experimental pancreatic cancer vaccine elicits durable immune responses in high-risk participants

Pancreatic ductal adenocarcinoma (PDAC) is an aggressive cancer that is often diagnosed at advanced stages and carries a low five-year survi

Research Spotlight: A New Era of Progress Against Pancreatic Cancer

May 27, 2026 - By Anna Berkenblit, MD, MMSc Editor’s note: The “Research Spotlight” series is written by Dr. Anna Berkenblit , PanCAN’s Chie

Anirban Maitra։ KRAS-Targeted Vaccine Feasibility in High-Risk Individuals for Pancreatic Cancer

Anirban Maitra, Laura and Isaac Perlmutter Professor of Pathology and Director of the Perlmutter Cancer Center, shared on X: “Congratulation

Experimental daraxonrasib pill extends survival for advanced pancreatic cancer patients, study finds

An experimental pill helped people with one of the most deadly cancers in the world live longer, researchers reported this weekend.

Results from small pancreatic cancer vaccine trial show promise

Pancreatic Cancer UK's Head of Research, Dr Madina Kara comments on early trial results which found seven of the eight people whose immune s